beta-alanine has been researched along with Thrombophilia in 20 studies
Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "New oral anticoagulant drugs are emerging as alternatives to warfarin for the prevention of stroke in patients with non-valvular atrial fibrillation." | 8.88 | An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. ( Ansell, J; Mantha, S, 2012) |
| " A second woman with primary APS experienced ischemic arterial strokes and right transverse-sigmoid sinus thrombosis after conversion to rivaroxaban." | 7.80 | Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. ( Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE, 2014) |
| "New oral anticoagulant drugs are emerging as alternatives to warfarin for the prevention of stroke in patients with non-valvular atrial fibrillation." | 4.88 | An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. ( Ansell, J; Mantha, S, 2012) |
| " A second woman with primary APS experienced ischemic arterial strokes and right transverse-sigmoid sinus thrombosis after conversion to rivaroxaban." | 3.80 | Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. ( Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE, 2014) |
| "Cardioembolic cerebral ischemia can be prevented." | 2.48 | [Prevention of cardioembolic stroke]. ( Gil Núñez, A, 2012) |
| " Clinicians are increasingly being challenged with making uncertain anticoagulant dosing decisions, as the optimal dosing strategy for most anticoagulants in the obese patient population remains unknown." | 2.47 | Anticoagulating obese patients in the modern era. ( Arya, R; Patel, JP; Roberts, LN, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 20 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, Y | 1 |
| Lip, GY | 1 |
| Prandoni, P | 1 |
| Barbar, S | 1 |
| Milan, M | 1 |
| Vedovetto, V | 1 |
| Pesavento, R | 1 |
| Potze, W | 1 |
| Arshad, F | 1 |
| Adelmeijer, J | 1 |
| Blokzijl, H | 1 |
| van den Berg, AP | 1 |
| Porte, RJ | 1 |
| Lisman, T | 1 |
| Ribés-Cruz, JJ | 1 |
| Torregrosa-Maicas, I | 1 |
| Ramos-Tomás, C | 1 |
| Solís-Salguero, MA | 1 |
| Puchades-Montesa, MJ | 1 |
| González-Rico, MA | 1 |
| Juan-García, I | 1 |
| Tomás-Simó, P | 1 |
| Tejedor-Alonso, S | 1 |
| Zambrano-Esteves, P | 1 |
| Miguel-Carrasco, A | 1 |
| Laroche, JP | 1 |
| Fenger-Eriksen, C | 1 |
| Münster, AM | 1 |
| Grove, EL | 1 |
| Tran, H | 1 |
| Joseph, J | 1 |
| Young, L | 1 |
| McRae, S | 1 |
| Curnow, J | 1 |
| Nandurkar, H | 1 |
| Wood, P | 1 |
| McLintock, C | 1 |
| Schaefer, JK | 1 |
| McBane, RD | 1 |
| Black, DF | 1 |
| Williams, LN | 1 |
| Moder, KG | 1 |
| Wysokinski, WE | 1 |
| Lane, DA | 1 |
| Wood, K | 1 |
| Dumont, B | 1 |
| Faille, D | 1 |
| Ajzenberg, N | 1 |
| Patel, JP | 1 |
| Roberts, LN | 1 |
| Arya, R | 1 |
| Masjuan, J | 1 |
| Gil Núñez, A | 1 |
| Zapata Wainberg, G | 1 |
| Ximénez-Carrillo Rico, A | 1 |
| Vivancos Mora, J | 1 |
| Sinauridze, EI | 1 |
| Panteleev, MA | 1 |
| Ataullakhanov, FI | 1 |
| Stöllberger, C | 1 |
| Rakusan, S | 1 |
| Wimpissinger, FT | 1 |
| Finsterer, J | 1 |
| Mantha, S | 1 |
| Ansell, J | 1 |
| Skjøth, F | 1 |
| Larsen, TB | 1 |
| Rasmussen, LH | 1 |
| Lillo-Le Louët, A | 1 |
| Wolf, M | 1 |
| Soufir, L | 1 |
| Galbois, A | 1 |
| Dumenil, AS | 1 |
| Offenstadt, G | 1 |
| Samama, MM | 1 |
| Harenberg, J | 1 |
| Marx, S | 1 |
| Wehling, M | 1 |
9 reviews available for beta-alanine and Thrombophilia
| Article | Year |
|---|---|
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; C | 2013 |
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; | 2014 |
New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Monitoring; | 2014 |
[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Tr | 2011 |
Anticoagulating obese patients in the modern era.
Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dab | 2011 |
[Prevention of cardioembolic stroke].
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Doubl | 2012 |
[Clinical management of the new anticoagulants].
Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Clinic | 2012 |
Anticoagulant therapy: basic principles, classic approaches and recent developments.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Factor Xa; Factor Xa In | 2012 |
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Tri | 2012 |
11 other studies available for beta-alanine and Thrombophilia
| Article | Year |
|---|---|
Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Te | 2013 |
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, | 2013 |
[New anticoagulants: stop or more?].
Topics: Adverse Drug Reaction Reporting Systems; Anticoagulants; Antidotes; Benzimidazoles; beta-Alanine; Ce | 2014 |
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagu | 2014 |
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; | 2014 |
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Contraindic | 2015 |
[Prevention of stroke in atrial fibrillation].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatra | 2012 |
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillati | 2012 |
Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Top | 2012 |
Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
Topics: Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement; Atrial Fibrillation; Benzimidazol | 2012 |
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Top | 2012 |